Literature DB >> 31471108

Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.

Adriana Forero1, Snehal Ozarkar1, Hongchuan Li2, Chia Heng Lee1, Emily A Hemann1, Marija S Nadjsombati1, Matthew R Hendricks1, Lomon So1, Richard Green3, Chandra N Roy4, Saumendra N Sarkar4, Jakob von Moltke1, Stephen K Anderson5, Michael Gale3, Ram Savan6.   

Abstract

Type I and III interferons (IFNs) activate similar downstream signaling cascades, but unlike type I IFNs, type III IFNs (IFNλ) do not elicit strong inflammatory responses in vivo. Here, we examined the molecular mechanisms underlying this disparity. Type I and III IFNs displayed kinetic differences in expression of IFN-stimulated genes and proinflammatory responses, with type I IFNs preferentially stimulating expression of the transcription factor IRF1. Type III IFNs failed to induce IRF1 expression because of low IFNλ receptor abundance and insufficient STAT1 activation on epithelial cells and thus did not activate the IRF1 proinflammatory gene program. Rather, IFNλ stimulation preferentially induced factors implicated in tissue repair. Our findings suggest that IFN receptor compartmentalization and abundance confer a spatiotemporal division of labor where type III IFNs control viral spread at the site of the infection while restricting tissue damage; the transient induction of inflammatory responses by type I IFNs recruits immune effectors to promote protective immunity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chemokines; epithelial cells; inflammation; interferon lambda; interferon regulatory factor 1; interferons

Mesh:

Substances:

Year:  2019        PMID: 31471108     DOI: 10.1016/j.immuni.2019.07.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  62 in total

Review 1.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

2.  Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.

Authors:  Shalini Tanwar; Cihan Oguz; Amina Metidji; Eric Dahlstrom; Kent Barbian; Kishore Kanakabandi; Lydia Sykora; Ethan M Shevach
Journal:  J Autoimmun       Date:  2020-07-22       Impact factor: 7.094

Review 3.  RNA regulatory mechanisms that control antiviral innate immunity.

Authors:  Nandan S Gokhale; Julian R Smith; Rachel D Van Gelder; Ram Savan
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

Review 4.  Who let the DoGs out? - biogenesis of stress-induced readthrough transcripts.

Authors:  Nicolle A Rosa-Mercado; Joan A Steitz
Journal:  Trends Biochem Sci       Date:  2021-09-03       Impact factor: 13.807

5.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

Authors:  Rishi R Goel; Xinghao Wang; Liam J O'Neil; Shuichiro Nakabo; Kowser Hasneen; Sarthak Gupta; Gustaf Wigerblad; Luz P Blanco; Jeffrey B Kopp; Maria I Morasso; Sergei V Kotenko; Zu-Xi Yu; Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

6.  Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.

Authors:  David Groeger; Elisa Schiavi; Ray Grant; Magdalena Kurnik-Łucka; David Michalovich; Rick Williamson; Soren Beinke; Barry Kiely; Cezmi A Akdis; Edith M Hessel; Fergus Shanahan; Liam O' Mahony
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

7.  Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.

Authors:  Abigail Vanderheiden; Philipp Ralfs; Tatiana Chirkova; Amit A Upadhyay; Matthew G Zimmerman; Shamika Bedoya; Hadj Aoued; Gregory M Tharp; Kathryn L Pellegrini; Candela Manfredi; Eric Sorscher; Bernardo Mainou; Jenna L Lobby; Jacob E Kohlmeier; Anice C Lowen; Pei-Yong Shi; Vineet D Menachery; Larry J Anderson; Arash Grakoui; Steven E Bosinger; Mehul S Suthar
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

8.  Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction.

Authors:  Frédérique Kok; Marcus Rosenblatt; Melissa Teusel; Jens Timmer; Marcel Schilling; Ursula Klingmüller; Tamar Nizharadze; Vladimir Gonçalves Magalhães; Christopher Dächert; Tim Maiwald; Artyom Vlasov; Marvin Wäsch; Silvana Tyufekchieva; Katrin Hoffmann; Georg Damm; Daniel Seehofer; Tobias Boettler; Marco Binder
Journal:  Mol Syst Biol       Date:  2020-07       Impact factor: 11.429

9.  Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.

Authors:  Jacob A Van Winkle; David A Constant; Lena Li; Timothy J Nice
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

10.  Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Authors:  Yongzhi Chen; Xuqiu Lei; Zhaozhao Jiang; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.